Recruiting studies: Ph Like

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01371630 Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+
Phase 1/Phase 2 · 1 location(s) · Novartis Pharmaceuticals · NCT07387926 Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Phase 1 · 2 location(s) · University of Chicago · NCT03571321 ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07454226 A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adole
Phase 2 · 155 location(s) · National Cancer Institute (NCI) · NCT06124157 RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
Phase N/A · 2 location(s) · Grupo Argentino de Tratamiento de la Leucemia Aguda · NCT05127148

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.